Non-O1	Non-O1	JJ	B-NP	O	
Vibrio cholerae	Vibrio_cholerae	NNP	I-NP	O	
bacteremia	bacteremia	NN	I-NP	O	
in	in	IN	B-PP	O	
patients	patient	NNS	B-NP	O	
with	with	IN	B-PP	O	
cirrhosis	cirrhosis	NN	B-NP	O	
:	:	:	O	O	
5-yr	5-yr	JJ	B-NP	O	
experience	experience	NN	I-NP	O	
from	from	IN	B-PP	O	
a	a	DT	B-NP	O	
single	single	JJ	I-NP	O	
medical	medical	JJ	I-NP	O	
center	center	NN	I-NP	O	
.	.	.	O	O	

To	To	TO	B-VP	O	
assess	assess	VB	I-VP	O	
the	the	DT	B-NP	O	
clinical	clinical	JJ	I-NP	O	
features	feature	NNS	I-NP	O	
and	and	CC	O	O	
susceptibility	susceptibility	NN	B-NP	O	
of	of	IN	B-PP	O	
cirrhotic	cirrhotic	JJ	B-NP	O	
patients	patient	NNS	I-NP	O	
to	to	TO	B-PP	O	
non-O1	non-O1	JJ	B-NP	O	
Vibrio cholerae	Vibrio_cholerae	NNP	I-NP	O	
bacteremia	bacteremia	NN	I-NP	O	
and	and	CC	O	O	
to	to	TO	B-VP	O	
provide	provide	VB	I-VP	O	
our	our	PRP$	B-NP	O	
therapeutic	therapeutic	JJ	I-NP	O	
experiences	experience	NNS	I-NP	O	
in	in	IN	B-PP	O	
this	this	DT	B-NP	O	
rare	rare	JJ	I-NP	O	
and	and	CC	I-NP	O	
high	high	JJ	I-NP	O	
lethal	lethal	JJ	I-NP	O	
infection	infection	NN	I-NP	O	
.	.	.	O	O	

Twenty	Twenty	CD	B-NP	O	
-	-	HYPH	I-NP	O	
eight	eight	CD	I-NP	O	
blood	blood	NN	I-NP	O	
culture	culture	NN	I-NP	O	
isolates	isolate	NNS	I-NP	O	
of	of	IN	B-PP	O	
non-O1	non-O1	JJ	B-NP	O	
V. cholerae	V._cholerae	NNP	I-NP	O	
were	be	VBD	B-VP	O	
identified	identify	VBN	I-VP	O	
by	by	IN	B-PP	O	
our	our	PRP$	B-NP	O	
clinical	clinical	JJ	I-NP	O	
microbiology	microbiology	NN	I-NP	O	
laboratory	laboratory	NN	I-NP	O	
between	between	IN	B-PP	O	
July	July	NNP	B-NP	O	
1989	1989	CD	I-NP	O	
and	and	CC	O	O	
June	June	NNP	B-NP	O	
1994	1994	CD	I-NP	O	
.	.	.	O	O	

Patients	Patient	NNS	B-NP	O	
with	with	IN	B-PP	O	
underlying	underlie	VBG	B-VP	O	
cirrhosis	cirrhosis	NN	B-NP	O	
and	and	CC	O	O	
the	the	DT	B-NP	O	
aforementioned	aforementioned	JJ	I-NP	O	
bacteremia	bacteremia	NN	I-NP	O	
were	be	VBD	B-VP	O	
retrospectively	retrospectively	RB	I-VP	O	
reviewed	review	VBN	I-VP	O	
.	.	.	O	O	

Twenty-one	Twenty-one	CD	B-NP	O	
cirrhotic	cirrhotic	JJ	I-NP	O	
patients	patient	NNS	I-NP	O	
(	(	(	O	O	
16	16	CD	B-NP	O	
male	male	JJ	I-NP	O	
,	,	,	O	O	
five	five	CD	B-NP	O	
female	female	JJ	I-NP	O	
;	;	:	O	O	
mean	mean	NN	B-NP	O	
age	age	NN	I-NP	O	
,	,	,	O	O	
50.9	50.9	CD	B-NP	O	
yr	yr	NN	I-NP	O	
;	;	:	O	O	
range	range	NN	B-NP	O	
28-67	28-67	CD	I-NP	O	
yr	yr	NN	I-NP	O	
)	)	)	O	O	
were	be	VBD	B-VP	O	
identified	identify	VBN	I-VP	O	
and	and	CC	O	O	
classified	classify	VBN	B-VP	O	
as	as	IN	B-PP	O	
Child	Child	NN	B-NP	O	
B	B	NN	I-NP	O	
(	(	(	O	O	
6	6	CD	B-NP	O	
cases	case	NNS	I-NP	O	
)	)	)	O	O	
and	and	CC	O	O	
Child	Child	NN	B-NP	B-protein	
C	C	NN	I-NP	I-protein	
(	(	(	O	O	
15	15	CD	B-NP	O	
cases	case	NNS	I-NP	O	
)	)	)	O	O	
.	.	.	O	O	

Bacteremic	Bacteremic	JJ	B-NP	O	
episodes	episode	NNS	I-NP	O	
occurred	occur	VBD	B-VP	O	
most	most	RBS	B-ADVP	O	
often	often	RB	I-ADVP	O	
from	from	IN	B-PP	O	
March	March	NNP	B-NP	O	
to	to	TO	B-PP	O	
September	September	NNP	B-NP	O	
.	.	.	O	O	

Seafood	Seafood	NN	B-NP	O	
ingestion	ingestion	NN	I-NP	O	
(	(	(	O	O	
seven	seven	CD	B-NP	O	
cases	case	NNS	I-NP	O	
)	)	)	O	O	
and	and	CC	O	O	
seawater	seawater	NN	B-NP	O	
exposure	exposure	NN	I-NP	O	
(	(	(	O	O	
two	two	CD	B-NP	O	
cases	case	NNS	I-NP	O	
)	)	)	O	O	
were	be	VBD	B-VP	O	
risk	risk	NN	B-NP	O	
factors	factor	NNS	I-NP	O	
,	,	,	O	O	
but	but	CC	O	O	
nosocomial	nosocomial	JJ	B-NP	O	
infections	infection	NNS	I-NP	O	
were	be	VBD	B-VP	O	
also	also	RB	I-VP	O	
noted	note	VBN	I-VP	O	
in	in	IN	B-PP	O	
six	six	CD	B-NP	O	
cases	case	NNS	I-NP	O	
.	.	.	O	O	

Presenting	Present	VBG	B-VP	O	
symptoms	symptom	NNS	B-NP	O	
and	and	CC	I-NP	O	
signs	sign	NNS	I-NP	O	
included	include	VBD	B-VP	O	
ascites	ascite	NNS	B-NP	O	
(	(	(	O	O	
95.2	95.2	CD	B-NP	O	
%	%	NN	I-NP	O	
)	)	)	O	O	
,	,	,	O	O	
fever	fever	NN	B-NP	O	
(	(	(	O	O	
81%	81%	CD	B-NP	O	
)	)	)	O	O	
,	,	,	O	O	
abdominal	abdominal	JJ	B-NP	O	
pain	pain	NN	I-NP	O	
(	(	(	O	O	
52.4	52.4	CD	B-NP	O	
%	%	NN	I-NP	O	
)	)	)	O	O	
,	,	,	O	O	
diarrhea	diarrhea	NN	B-NP	O	
(	(	(	O	O	
33.3	33.3	CD	B-NP	O	
%	%	NN	I-NP	O	
)	)	)	O	O	
,	,	,	O	O	
and	and	CC	O	O	
cellulitis	cellulitis	NN	B-NP	O	
with	with	IN	B-PP	O	
bullae	bullae	NN	B-NP	O	
formation	formation	NN	I-NP	O	
(	(	(	O	O	
19%	19%	CD	B-NP	O	
)	)	)	O	O	
.	.	.	O	O	

Concurrent	Concurrent	JJ	B-NP	O	
spontaneous	spontaneous	JJ	I-NP	O	
bacterial	bacterial	JJ	I-NP	O	
peritonitis	peritonitis	NN	I-NP	O	
was	be	VBD	B-VP	O	
determined	determine	VBN	I-VP	O	
in	in	IN	B-PP	O	
10	10	CD	B-NP	O	
cases	case	NNS	I-NP	O	
,	,	,	O	O	
seven	seven	CD	B-NP	O	
with	with	IN	B-PP	O	
positive	positive	JJ	B-NP	B-cell_line	
ascites	ascite	NNS	I-NP	I-cell_line	
cultures	culture	NNS	I-NP	I-cell_line	
.	.	.	O	O	

Antibiotic	Antibiotic	JJ	B-NP	O	
therapy	therapy	NN	I-NP	O	
(	(	(	O	O	
either	either	CC	O	O	
cephalothin	cephalothin	NN	B-NP	O	
with	with	IN	B-PP	O	
gentamicin	gentamicin	NN	B-NP	O	
or	or	CC	I-NP	O	
ceftriaxone	ceftriaxone	NN	I-NP	O	
alone	alone	RB	B-ADVP	O	
)	)	)	O	O	
cured	cure	VBN	B-VP	O	
most	most	JJS	B-NP	O	
of	of	IN	B-PP	O	
the	the	DT	B-NP	O	
bacteremic	bacteremic	JJ	I-NP	O	
episodes	episode	NNS	I-NP	O	
.	.	.	O	O	

The	The	DT	B-NP	O	
overall	overall	JJ	I-NP	O	
case	case	NN	I-NP	O	
-	-	HYPH	B-NP	O	
fatality	fatality	NN	I-NP	O	
rate	rate	NN	I-NP	O	
was	be	VBD	B-VP	O	
23.8	23.8	CD	B-NP	O	
%	%	NN	I-NP	O	
,	,	,	O	O	
but	but	CC	O	O	
75%	75%	CD	B-NP	O	
of	of	IN	B-PP	O	
the	the	DT	B-NP	O	
deaths	death	NNS	I-NP	O	
were	be	VBD	B-VP	O	
observed	observe	VBN	I-VP	O	
in	in	IN	B-PP	O	
patients	patient	NNS	B-NP	O	
with	with	IN	B-PP	O	
skin	skin	NN	B-NP	O	
manifestation	manifestation	NN	I-NP	O	
.	.	.	O	O	

Patients	Patient	NNS	B-NP	O	
with	with	IN	B-PP	O	
decompensated	decompensate	VBN	B-NP	O	
cirrhosis	cirrhosis	NN	I-NP	O	
are	be	VBP	B-VP	O	
susceptible	susceptible	JJ	B-ADJP	O	
to	to	TO	B-PP	O	
non-O1	non-O1	JJ	B-NP	O	
V. cholerae	V._cholerae	NNP	I-NP	O	
bacteremia	bacteremia	NN	I-NP	O	
and	and	CC	O	O	
should	should	MD	B-VP	O	
not	not	RB	I-VP	O	
ingest	ingest	VB	I-VP	O	
raw	raw	JJ	B-NP	O	
seafood	seafood	NN	I-NP	O	
or	or	CC	O	O	
expose	expose	VB	B-VP	O	
skin	skin	NN	B-NP	O	
wounds	wound	NNS	I-NP	O	
to	to	TO	B-VP	O	
salt	salt	VB	I-VP	O	
water	water	NN	B-NP	O	
.	.	.	O	O	

A	A	DT	B-NP	O	
high	high	JJ	I-NP	O	
index	index	NN	I-NP	O	
of	of	IN	B-PP	O	
suspicion	suspicion	NN	B-NP	O	
and	and	CC	O	O	
early	early	JJ	B-NP	O	
administration	administration	NN	I-NP	O	
of	of	IN	B-PP	O	
antibiotics	antibiotic	NNS	B-NP	O	
may	may	MD	B-VP	O	
lower	lower	VB	I-VP	O	
the	the	DT	B-NP	O	
mortality	mortality	NN	I-NP	O	
rate	rate	NN	I-NP	O	
.	.	.	O	O	

